CA1190855A — Treatment of osteitis
Assigned to Ed Geistlich Soehne AG fuer Chemische Industrie · Expires 1985-07-23 · 41y expired
What this patent protects
ABSTRACT "Treatment of osteitis" A composition comprising a resorbable aqueous gel having dissolved or dispersed therein one or more water-soluble medicaments is of use in the treatment of wounds. Such a composition is of use in a method of healing…
USPTO Abstract
ABSTRACT "Treatment of osteitis" A composition comprising a resorbable aqueous gel having dissolved or dispersed therein one or more water-soluble medicaments is of use in the treatment of wounds. Such a composition is of use in a method of healing an infection in a cavity in bone or other tissue whereby the resorbable aqueous gel is placed in the cavity and allowed to remain there until resorbed, the aqueous phase of the gel containing the water soluble medicament. The medicament is preferably an antibiotic or a methylol transfer antibacterial.
Drugs covered by this patent
- Heparin Sodium In Plastic Container (Heparin Sodium) · Fresenius Kabi
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.